Maintenance Therapy
16
7
8
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
44%
7 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (16)
Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy
A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
Nevirapine / Lamivudine for HIV Maintenance Therapy
Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma
A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma
Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)
Physical Activity to Improve Patient Reported Outcomes for Adults With Acute Leukemia
Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis
Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV)
Maintenance Therapy of Narrow-band UV-B Therapy in Patients With Vitiligo
Maintenance Therapy of 308-nm Excimer Laser Therapy in Patients With Vitiligo